{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:44:06Z","timestamp":1792622646886,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.nmd.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T03:34:25Z","timestamp":1709782465000},"page":"36-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16\u201318 June 2023, Hoofddorp, The Netherlands"],"prefix":"10.1016","volume":"37","author":[{"given":"James B.","family":"Lilleker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Naddaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan G.J.","family":"Saris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad C.","family":"Weihl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Alexanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Badrising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Bhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"De Bleecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Breeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Diederichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mridul","family":"Johari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lilleker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahseen","family":"Mozaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Mischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Naddaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrilee","family":"Needham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Oldfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-0588","authenticated-orcid":false,"given":"Christiaan","family":"Saris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Weihl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2024.03.001_bib0001","first-page":"1586","article-title":"Sporadic inclusion body myositis and other rimmed vacuolar myopathies","volume":"25","author":"Weihl","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.nmd.2024.03.001_bib0002","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC international workshop: inclusion body myositis, 2-4 december 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.03.001_bib0003","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0004","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(19)30200-5","article-title":"Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Hanna","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0006","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1474-4422(23)00275-2","article-title":"Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"22","author":"Machado","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0007","doi-asserted-by":"crossref","first-page":"e2653","DOI":"10.1212\/WNL.0000000000012004","article-title":"Epidemiology and Natural History of Inclusion Body Myositis: a 40-Year Population-Based Study","volume":"96","author":"Shelly","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0008","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nmd.2016.05.014","article-title":"213th ENMC International Workshop: outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015","volume":"26","author":"Benveniste","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.03.001_bib0009","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mus.27716","article-title":"Atypical presentations of inclusion body myositis: clinical characteristics and long-term outcomes","volume":"66","author":"Alamr","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","author":"Lloyd","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0011","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/mus.24661","article-title":"Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis","volume":"52","author":"Tasca","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0012","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mus.26875","article-title":"Ultrasound can differentiate inclusion body myositis from disease mimics","volume":"61","author":"Leeuwenberg","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0051","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.nmd.2023.08.014","article-title":"group EMIiIIMws. 255th ENMC workshop: muscle imaging in idiopathic inflammatory myopathies. 15th January, 16th January and 22nd January 2021 - virtual meeting and hybrid meeting on 9th and 19th September 2022 in Hoofddorp, The Netherlands","volume":"33","author":"de Visser","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.03.001_bib0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/CND.0000000000000353","article-title":"Diagnostic accuracy of anti-CN1A on the diagnosis of inclusion body myositis. A hierarchical bivariate and bayesian meta-analysis","volume":"23","author":"Mavroudis","year":"2021","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2024.03.001_bib0014","first-page":"240","article-title":"Inclusion body myositis","volume":"25","author":"Yunis","year":"1971","journal-title":"Lab Invest"},{"key":"10.1016\/j.nmd.2024.03.001_bib0015","first-page":"213","article-title":"A myopathy with cellular inclusions","volume":"90","author":"Adams","year":"1965","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1016\/j.nmd.2024.03.001_bib0016","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1126\/science.158.3807.1453","article-title":"Myxovirus-like structures in a case of human chronic polymyositis","volume":"158","author":"Chou","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.nmd.2024.03.001_bib0017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ana.26412","article-title":"Epidemiology, survival, and clinical characteristics of inclusion body myositis","volume":"92","author":"Lindgren","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0018","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1212\/WNL.0000000000206777","article-title":"Clinical subgroups and factors associated with progression in patients with inclusion body myositis","volume":"100","author":"Michelle","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0019","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.26914","article-title":"Myopathies with finger flexor weakness: not only inclusion-body myositis","volume":"62","author":"Nicolau","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0020","first-page":"340","article-title":"Two emerging phenotypes of atypical inclusion body myositis: illustrative cases","volume":"41","author":"Salam","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0021","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00415-009-5229-9","article-title":"Detecting dysphagia in inclusion body myositis","volume":"256","author":"Cox","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0022","first-page":"929","article-title":"An appraisal of current dysphagia diagnosis and treatment strategies","volume":"10","author":"Kaindlstorfer","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0023","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1007\/s00415-022-11028-8","article-title":"Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis","volume":"269","author":"Witting","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0024","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.nmd.2014.08.003","article-title":"Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis","volume":"24","author":"Rodriguez Cruz","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.clinph.2013.03.002","article-title":"Sleep disordered breathing in a cohort of patients with sporadic inclusion body myositis","volume":"124","author":"Della Marca","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0026","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1212\/01.WNL.0000145834.17020.86","article-title":"Primary respiratory failure in inclusion body myositis","volume":"63","author":"Voermans","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012004","article-title":"Epidemiology and natural history of inclusion body myositis: a 40-year population-based study","author":"Shelly","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0028","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00005792-200109000-00006","article-title":"Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period","volume":"80","author":"Felice","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nmd.2024.03.001_bib0029","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/rheumatology\/keab716","article-title":"Survival and associated comorbidities in inclusion body myositis","volume":"61","author":"Naddaf","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.nmd.2024.03.001_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JND-160198","article-title":"A systematic review and meta-analysis of prevalence studies of sporadic inclusion body myositis","volume":"4","author":"Callan","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2024.03.001_bib0031","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I","article-title":"Prevalence of sporadic inclusion body myositis in Western Australia","volume":"23","author":"Phillips","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0032","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jocn.2008.01.011","article-title":"Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis","volume":"15","author":"Needham","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nmd.2024.03.001_bib0033","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1756-185X.2011.01669.x","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases","volume":"16","author":"Tan","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.nmd.2024.03.001_bib0034","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2014.09.012","article-title":"Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches","volume":"22","author":"Mastaglia","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nmd.2024.03.001_bib0035","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1007\/s00415-023-11878-w","article-title":"Inclusion body myositis with early onset: a population-based study","volume":"270","author":"Lindgren","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0036","doi-asserted-by":"crossref","first-page":"e12931","DOI":"10.1111\/bpa.12931","article-title":"Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing","volume":"31","author":"Hedberg-Oldfors","year":"2021","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0037","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/nan.12149","article-title":"Mitochondrial and inflammatory changes in sporadic inclusion body myositis","volume":"41","author":"Rygiel","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0038","first-page":"618","article-title":"p62 is a component of SMI-31 positive inclusions in sporadic inclusion body myositis","volume":"14","author":"Engel","year":"2004","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.nmd.2024.03.001_bib0039","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nmd.2019.03.002","article-title":"1st ENMC European meeting: the EURO-NMD pathology working group recommended standards for muscle pathology Amsterdam, The Netherlands, 7 December 2018","volume":"29","author":"Udd","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.03.001_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00401-023-02669-8","article-title":"Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases","volume":"147","author":"Nelke","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0041","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","article-title":"Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken","volume":"129","author":"Benveniste","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0042","first-page":"24","article-title":"Inflammasome in skeletal muscle: NLRP3 is an inflammatory cell stress component in inclusion body myositis","author":"Kummer","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2024.03.001_bib0043","doi-asserted-by":"crossref","first-page":"53524","DOI":"10.1074\/jbc.M408473200","article-title":"Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes","volume":"279","author":"Christensen","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2024.03.001_bib0044","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.expneurol.2018.08.006","article-title":"Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions","volume":"309","author":"Tawara","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0045","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nmd.2024.03.001_bib0046","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2024.03.001_bib0047","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2024.03.001_bib0048","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","article-title":"A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities","volume":"134","author":"Cox","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2024.03.001_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1146015","article-title":"Imaging biomarkers in the idiopathic inflammatory myopathies","volume":"14","author":"Zubair","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0050","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1212\/WNL.0000000000200776","article-title":"Longitudinal changes in MRI muscle morphometry and composition in people with inclusion body myositis","volume":"99","author":"Laurent","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0052","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0022-3476(82)80286-2","article-title":"Ultrasound imaging in the diagnosis of muscle disease","volume":"101","author":"Heckmatt","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2024.03.001_bib0053","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mus.26411","article-title":"Assessing the accuracy of neuromuscular ultrasound for inclusion body myositis","volume":"59","author":"Karvelas","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0054","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ultrasmedbio.2021.04.019","article-title":"Musculoskeletal ultrasound in inclusion body myositis: a comparative study with magnetic resonance imaging","volume":"47","author":"Guimaraes","year":"2021","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mus.27833","article-title":"Correlation of muscle ultrasound with clinical and pathological findings in idiopathic inflammatory myopathies","volume":"68","author":"Yoshida","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0056","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","article-title":"Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain","volume":"50","author":"Choi","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nmd.2024.03.001_bib0057","doi-asserted-by":"crossref","first-page":"b2680","DOI":"10.1136\/bmj.b2680","article-title":"How citation distortions create unfounded authority: analysis of a citation network","volume":"339","author":"Greenberg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.nmd.2024.03.001_bib0058","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/annrheumdis-2018-214644","article-title":"[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis","volume":"78","author":"Lilleker","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nmd.2024.03.001_bib0059","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0060","doi-asserted-by":"crossref","first-page":"e20266","DOI":"10.1371\/journal.pone.0020266","article-title":"Autoantibodies against a 43KDa muscle protein in inclusion body myositis","volume":"6","author":"Salajegheh","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2024.03.001_bib0061","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.24919","article-title":"Pathomechanisms of anti-cytosolic 5\u2032-nucleotidase 1A autoantibodies in sporadic inclusion body myositis","volume":"81","author":"Tawara","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0062","doi-asserted-by":"crossref","first-page":"384","DOI":"10.55563\/clinexprheumatol\/r625rm","article-title":"Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis","volume":"40","author":"Salam","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0063","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/acr2.11510","article-title":"Anti-valosin-containing protein (VCP\/p97) autoantibodies in inclusion body myositis and other inflammatory myopathies","volume":"5","author":"Amlani","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1020113","article-title":"Inclusion body myositis: update on the diagnostic and therapeutic landscape","volume":"13","author":"Naddaf","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154966","article-title":"The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis","volume":"127","author":"De Paepe","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.nmd.2024.03.001_bib0066","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0067","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JND-170234","article-title":"Cytokine profiling of serum allows monitoring of disease progression in inclusion body myositis","volume":"4","author":"Badrising","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2024.03.001_bib0068","doi-asserted-by":"crossref","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","article-title":"Identification of distinctive interferon gene signatures in different types of myositis","volume":"93","author":"Pinal-Fernandez","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577833","article-title":"Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy","volume":"365","author":"Oda","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0070","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","article-title":"TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia","volume":"79","author":"Weihl","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2024.03.001_bib0071","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","article-title":"Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.03.001_bib0072","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00401-010-0769-8","article-title":"TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies","volume":"120","author":"Kuiperij","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0073","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2051-5960-1-29","article-title":"Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies","volume":"1","author":"Hiniker","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nmd.2024.03.001_bib0074","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","article-title":"TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A","volume":"603","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2024.03.001_bib0075","doi-asserted-by":"crossref","first-page":"eabi9196","DOI":"10.1126\/scitranslmed.abi9196","article-title":"Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis","volume":"14","author":"Britson","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nmd.2024.03.001_bib0076","article-title":"A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS","author":"Irwin","year":"2023","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.nmd.2024.03.001_bib0077","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/112.3.727","article-title":"Inclusion body myositis. Observations in 40 patients","volume":"112","author":"Lotz","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2024.03.001_bib0078","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ymthe.2017.02.015","article-title":"Follistatin gene therapy for sporadic inclusion body myositis improves functional outcomes","volume":"25","author":"Mendell","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2024.03.001_bib0079","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1016\/S2665-9913(20)30280-0","article-title":"Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial","volume":"3","author":"Benveniste","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.10121","article-title":"Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo","volume":"51","author":"Badrising","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0081","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","article-title":"A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM","volume":"56","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0082","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0083","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/WNL.57.9.1566","article-title":"Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis","volume":"57","author":"Muscle Study","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0084","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/01.WNL.0000134675.98525.79","article-title":"Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis","volume":"63","author":"Muscle Study","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0085","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/WNL.58.7.1081","article-title":"A pilot randomized trial of oxandrolone in inclusion body myositis","volume":"58","author":"Rutkove","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0086","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004150050005","article-title":"High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study","volume":"247","author":"Walter","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0087","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/brain\/awz207","article-title":"Highly differentiated cytotoxic T cells in inclusion body myositis","volume":"142","author":"Greenberg","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2024.03.001_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1153789","article-title":"Uncovering the significance of expanded CD8(+) large granular lymphocytes in inclusion body myositis: insights into T cell phenotype and functional alterations, and disease severity","volume":"14","author":"McLeish","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0089","doi-asserted-by":"crossref","first-page":"e2212","DOI":"10.1212\/WNL.0000000000201103","article-title":"Morphologic and molecular patterns of polymyositis with mitochondrial pathology and inclusion body myositis","volume":"99","author":"Kleefeld","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-021-01017-7","article-title":"Updates on the opathies","volume":"23","author":"Uruha","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.nmd.2024.03.001_bib0091","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1007\/s00415-023-11779-y","article-title":"Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis","volume":"270","author":"Vogt","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0092","doi-asserted-by":"crossref","first-page":"e1158","DOI":"10.1212\/WNL.0000000000207596","article-title":"Imaging With PET\/CT of Diffuse CD8 T-Cell Infiltration of Skeletal Muscle in Patients With Inclusion Body Myositis","volume":"101","author":"Quinn","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2024.03.001_bib0093","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200168","article-title":"Study to assess content validity and interrater and intrarater reliability of the inclusion body myositis functional rating scale","volume":"13","author":"Symonds","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.nmd.2024.03.001_bib0094","first-page":"261","article-title":"In-patient comorbidities in inclusion body myositis: a United States national in-patient sample-based study","volume":"41","author":"Ma","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0095","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/rheumatology\/kead194","article-title":"Diagnosing and managing dysphagia in inclusion body myositis: a systematic review","volume":"62","author":"Ambrocio","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.nmd.2024.03.001_bib0096","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nmd.2014.04.009","article-title":"Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials","volume":"24","author":"Hogrel","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.03.001_bib0097","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s10067-016-3234-9","article-title":"Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus","volume":"35","author":"Pinto","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.nmd.2024.03.001_bib0098","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.semarthrit.2020.06.014","article-title":"Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: a prospective cohort study","volume":"50","author":"Landon-Cardinal","year":"2020","journal-title":"Semin Arthritis Rheum"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T23:26:51Z","timestamp":1717284411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896624000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":98,"alternative-id":["S0960896624000543"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2024.03.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16\u201318 June 2023, Hoofddorp, The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}